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ABSTRACT
Objective: The aim of this study was to quantify by immunohistochemistry the number of myoepithelial cells (MyECs) 
in pleomorphic adenomas (PAs). Material and methods: We retrieved the paraffin cubes of 27 PAs, new slides were done 
and they were stained with anti-S100 protein antibody. The amount of S-100 protein positive cells was quantified, their 
morphology was recorded and comparison among MyEC number with age, gender and involved gland were also done. 
Results: With S-100 protein, MyECs in normal salivary gland tissue were seen surrounding the ductual structures only. 
In the analysed PAs a mean of 27.4% of the neoplastic cells were positive to the antibody. With the exception of one PA, 
in all the analysed cases the plasmacytoid cells were the most commonly identified cells (48,6%). Conclusions: Results 
of this study suggest that MyECs do not constitute the main cellular component of the neoplastic compartment in PAs 
and corroborate the previously reported evidence by different au-thors, who studying the PAs suggested that MyECs 
does not comprise the main cellular neoplastic component of these entities.
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RESUMEN
Objetivo: El objetivo de este estudio fue cuantificar por medio de inmunohistoquí-mica el número de células mioepiteliales 
(CMs) en adenomas pleomorfos (APs). Mate-rial y Métodos: Se recuperaron los cubos de 27 APs y se hicieron nuevas 
laminillas, las que se tiñeron con un anticuerpo anti-proteína S-100, se contó el número de células S-100 positivas, se 
registró su morfología y se hicieron comparaciones del número de CMs tomando en cuenta el sexo, edad y glándula de 
origen. Resultados: Se observó que en el tejido glandular normal, las CMs solo se observaron alrededor de las estruc-
turas ductuales. En los APs analizados se encontró que en promedio, solamente el 27,4% de las células neoplásicas fueron 
positivas a este anticuerpo. Con excepción de un AP, en todos los casos analizados las células plasmocitoides fueron las 
células más comúnmente encontradas (48,6%). Conclusiones: Los resultados de este estudio su-gieren que las CMs no 
forman el componente celular principal del compartimiento neo-plásico de los APs y confirman las evidencias encon-
tradas desde hace varios años, por diferentes autores, quienes estudiando los APs, sugirieron que las CMs no forman la 
mayor parte de las células neoplásicas en estas entidades.
Palabras clave: Adenoma pleomorfo, tumores de glándulas salivales, células mioepiteliales, proteína S-100.
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INTRODUCTION
Pleomorphic adenoma (PA) is the most common epithelial 
neoplasm arising in the salivary gland tissue. Its more fre-
quent extra-oral location is parotid and intraorally, pal-ate is 
the most common place. Among sexes, PA predominates in 
males (1-5). Differ-ences amongst age, gender and location 
have been reported (2-5).
PA is characterized by its polymorphic microscopic appea-
rance and several cellu-lar structures have been identified. 
This polymorphic appearance consists in that the main 
cellular components of this neoplasm (ductual and myoe-
pithelial cells) are ar-ranged forming different structures: 
ducts, solid groups or sheets, hyaline, mixocondroid and 
bone-like tissue as well as keratin pearls and epidermoid 
metaplastic zones are also seen. Frequently, myoepithelial 
cells (MyECs) display different shapes: stellate, polygonal, 
plasmacytoid, fusiform and round or oval.
MyECs have been considered as the main cells composing 
the neoplastic cell compartment in the PAs (6-9), but this 
fact was challenged when we carefully analysed the minor 
results published by several authors (10-14). In these articles, 
the authors mentioned that PA cells related as MyECs did 
not show enough features to be consid-ered as such. Reading 
of these comments let us to think that MyECs are not the 
most common cells in PA. Also, we made an extensive review 
of the literature searching on works related to accurately 
confirm our assumption, but we were not able to find any 
work dealing on quantification of MyECs in PAs.
The aim of this study was to quantitate the MyEC numbers 
in different areas of PA cases.
MATERIAL AND METHODS
27 PAs from the files of our Oral Pathology Laboratory 
located in the Facultad de Odontología, UNAM (Mexico 
City) were retrieved and their clinical features analysed, 
microscopic slides were re-evaluated according to the pa-
rameters of the 2005 WHO Histological Classification of 
Tumours of Salivary Glands (1). Clinical data assessed were 
age, gender and location of the tumours. New 5µ paraffin 
embedded slides were done and all slides received previous 
treatment with 0,1% trypsin solution in oven at 35° C for 5 
minutes. For immunohistochemical staining with the anti-S-
100 protein MoAb (Dako) the slides were treated with citrate 
buffer during three min in a microwave oven at 600W, was-
hings were made with PBS-Triton, the streptavidin-biotin 
method was em-ployed and the slides were counterstained 
with Harris’ haematoxylin. Negative controls omitting the 
antibody were done. Positivity was matched: 0= negative; 1= 
slight; 2= moderate; 3= strong and 4= very strong. Control 
slides from normal parotid salivary glands were used and 
immunostained as above.
For the microscopic review, a Carl Zeiss microscope was 
employed by two experi-enced Oral Pathologists, five ran-
domly selected 40X microscopic fields were analysed and 
all the cells contained in the area of an ocular graticule 
were counted. S-100 protein positive cells included were: 
fusiform, plasmocytoid, chondroid, myxoid and epithelial-
like. A previous calibration of the examiners was performed, 
inter-examiners’ correlation was 94% and intra-examiner 
correlation was 95%. Review of the stained slides was double 
blind and a mean of the lectures obtained by both exami-
ners was considered correct. MyEC counts are expressed as 
number of cells per 40X field.
RESULTS
From the 27 patients there were 20 females and 7 males. 
Patient’s age was be-tween 14 and 72 years with a mean 
age of  35,1 years (in three cases age was not specified). 
Location of the tumours was more frequent in palate and 
submandibular gland (Table 1). Of the 27 PA cases, 40 slides 
were reviewed.
All the reviewed cases showed the typical features of AP as 
it was in the WHO guidelines (1). All the tumours were for-
med by numerous ductiform structures, myoepi-thelial cells 
showed different shapes forming solid structures, chondroid 
and myxoid tissue, mucoid or diffusely arranged with scarce 
stromal tissue (Fig. 1).
Positivity to S-100 protein antibody in the control normal 
salivary gland tissues was found in the myoepithelial cells 
surrounding the ductual structures only.
PA cases showed positivity in the cells located around the 
pseudo-ductual struc-tures and in the fusiform, plasmo-
cytoid, myxoid, chondroid and epithelial-like cells (Fig. 2 
and 3). Despite our efforts to get positivity in the slides from 
four cases, they showed no positive immunostaining. 
In the analysed slides, 13.233 neoplastic cells (mean= 575 
cells/tumour) were quantified. Number of  positive cells 
per microscopic field (40X) varied from 12 cells in a pre-
dominately chondromyxoid tumour to 617 cells in the more 
cellular tumours.  
LOCATION NUMBER % 
PALATE 12 44,5 
SUBMANDIBULAR 5 18,5 
PAROTID 4 14,8 
UPPER LIP 2 7,4 
BUCCAL MUCOSA 2 7,4 
FLOOR OF THE MOUTH 1 3,7 
UNKNOWN 1 3,7 
TOTAL 27 100 
Table 1. Location of the analised cases
E112
Med Oral Patol Oral Cir Bucal 2007;12:E110-5.                                                            � Myoepithelium in pleomorphic adenomas                                                         Med Oral Patol Oral Cir Bucal 2007;12:E110-5.                                                              � Myoepithelium in pleomorphic adenomas
 
Positivity varied from 3% to 80% of the total neoplastic 
cell number. Of the 13.233 neoplastic cells, 3.636 (27,4%) 
were S-100 protein positive cells. Plasmacytoid cells were 
the more common S-100 positive cells; they were 1.769 cells 
(13,4%) of the total neoplastic cells and comprised 48,6% 
of the S-100 positive cells. Chondromyxoid cells found in 
this study were 942 (7,1%) of the total cell quantitation and 
25,9% of the S-100 positive cells. Fusiform cells were 640 
comprising 4,8% of the total cell count and 17,6% of the S-
100 positive cells. S-100 positive cells grouped in solid areas 
were the less commonly found cells; they were 285 cells and 
comprised 2,1% of the total cellular count and 7,9% of the 
S-100 positive cells.
Our total cell quantitation (Table 2) showed that PAs were 
more cellular in 20 years or younger patients (mean= 840,7 
cells/tumour), followed by patients older than 50 years 
(mean= 610 cells/tumour). PAs from women were more 
cellular than those from men. In men tumours there were 
counted 3.102 cells and a mean of 443,1 cells/tumour was 
found. In women 10.131 cells were found with a mean of 
506,5 cells/tumour. Tumours located in parotid were the 
more cellular AP’s (mean= 613,5 cells/tumour), followed 
by those located in submandibular gland (mean= 554,6 
cells/tumour). Other cell counts by age and location are 
also shown in table 2.
S-100 protein positive cells were more frequently found 
in males (mean= 147,6 cells/tumour) followed by female 
tumours (mean= 130,6 cells/tumour). Also, these cells were 
more numerous in 20 years or younger patients (mean= 349,3 
cells/tumour), fol-lowed by tumours in patients between 31 
to 40 years (mean= 146,7 cells/tumour). Tu-mours located in 
submandibular glands were the more cellular AP’s (mean= 
198,6 cells/tumour), followed by those located in parotid 
glands (mean= 179,5 cells/tumour). All S-100 positive cell 
counts by age and location are included in table 3.
In tumours from labial glands, only 18 S-100 protein positive 
cells were found (3,04%) and all of them were of the fusiform 
type. However, in the PAs located in glands of the buccal 
mucosa 999 neoplastic cells were quantified, of them, 130 
were S-100 positive (13%) and plasmacytoid cells predomi-
nate (42,3%). In tumours located in pal-ate 6.030 cells were 
counted, of them, 1.557 were S-100 protein positive cells 
(25,8%). The most common MyEC identified was the plas-
macytoid cell (61,2%) also. Those PAs situated in parotid 
glands contained 2.454 neoplastic cells, of them, 718 were 
S-100 protein positive (29,26%) and also, the plasmacytoid 
cell was the more commonly iden-tified MyEC (36,1%). 
From the PAs located in the floor of the mouth 252 cells were 
counted, of them, 112 were S-100 protein positive (44,4%) 
and unexpectedly epithelial-like cells in solid groups were 
the most commonly seen MyEC (44,6%). Those tumours 
found in the submandibular salivary glands contained 2.773 
cells, of them, 993 were S-100 protein positive (35,8%) and 
plasmocytoid cells were the most commonly seen MyEC. 
Relative frequency of other cells in the studied tumours is 
also presented in table 4.
Fig. 1. Photomicrograph 
showing a predominately epi-
thelial tumour with numerous 
duct-like structures, some of 
them showing mucous secre-
tion, scarce hyaline stroma 
and many myoepithelial cells. 
H & E. 100X.
Fig. 2. Numerous S-100 po-
sitive myoepithelial cells of 
variable morphology can be 
seen. S-100 protein, streptavi-
din-biotin technique. 200X.
Fig. 3. Epithelioid, fusiform 
and plasmacytoid myoe-
pithelial cells are observed 











AGE    
14-20 2,522 3 840,7 
21-30 3,686 7 526,6 
31-40 846 4 211,5 
41-50 1,974 5 394,8 
>50 3,050 5 610 
UNKNOWN 1,155 3  
TOTAL 13,233 27  
LOCATION    
PALATE 6,030 12 502 
SUBMANDIBULAR 2,773 5 554,6 
PAROTID 2,454 4 613,5 
UPPER LIP 591 2 295,5 
BUCCAL MUCOSA 999 2 499,5 
FLOOR OF THE MOUTH 252 1 252 
UNKNOWN 134 1 134 






AGE    
14-20 1,048 3 349,3 
21-30 766 7 109,4 
31-40 587 4 146,7 
41-50 501 5 100,2 
>50 594 5 118,8 
UNKNOWN 140 3  
TOTAL 3,591 27  
LOCATION    
PALATE 1,557 12 129,7 
SUBMANDIBULAR 993 5 198,6 
PAROTID 718 4 179,5 
UPPER LIP 18 2 9 
BUCCAL MUCOSA 130 2 65 
FLOOR OF THE MOUTH 112 1 112 
UNKNOWN 108 1 108 
TOTAL 3,636 27  
Table 2. Total number of cells in the studied sample. Table 3. Number of s-100 positive cells in the pa’s.
Table 4. Distribution of s-100 positive cells by location in the studied pa’s.
LOCATION KIND OF MYOEPITHELIAL CELLS 
 PLASMACYTOID CONDROMIXOID FUSIFORM EPITHELIAL-LIKE TOTAL 
     
PALATE 953 273 273 58 1,557 
SUBMANDIBULAR 436 302 191 64 993 
PAROTID 279 240 95 104 718 
UPPER LIP 0 0 18 0 18 
BUCCAL MUCOSA 55 32 34 9 130 
FLOOR OF THE MOUTH 40 7 15 50 112 
UNKNOWN 6 88 14 0 108 
TOTAL 1,769 942 640 285 3,636 
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DISCUSSION
There are many studies on the immunohistochemical featu-
res o the MyECs using numerous monoclonal an polyclonal 
antibodies as cytokeratins (CK-7,8,14, AE1-AE3, K18.12, 
KL1), muscle specific proteins as alpha-smooth muscle ac-
tin, muscle specific actin (HHF-35), calponin, myoglobin, 
smooth muscle myosin, smooth muscle myosin heavy chains, 
S-100 protein and its sub-units, vimentin, P63, CD10, D2-
40, laminin, maspin, MNF116, EMA, collagen type IV, 
H-caldesmon, iNOS, ß-catenin and others (9,15-27). All 
these studies showed that MyECs showed widely variable 
results (some times they were positive, and some times they 
were negative) and also, these studies showed they showed 
differences in the intensity of the cellular immunostaining. 
Results from these studies clearly demonstrate that MyECs 
have a very wide immunoprofile and that any of the used 
antibodies is specific to accurately detect the MyECs.
Writing on the histogenesis and electron microscopic featu-
res of the PA neoplastic cells, Dardick et al determined that 
putative MyECs found in chondroid and myxoid ar-eas of 
their studied PA cases, these cells showed no satisfactory 
ultrastructural features of MyECs (10). In another study 
(11), Latkovich and Johnson found no positivity for markers 
to MyECs in a malignant PA. Hirano et al found that only 
few cells in their stud-ied PAs showed positivity to actin 
antibodies (12). Palmer et al (13) demonstrated that MyECs 
were relatively rare in the majority of their studied PAs and 
that many of the cells, which have been classically descri-
bed as MyECs in routine preparations, they did not clearly 
show this type of differentiation. In another study, Palmer 
et al (14) reported that ultrastructurally, typical MyECs 
were rarely encountered even in situations where they are 
reported to occur. In the Erlandson et al study (6), these 
authors reported that double immunostaining to vimentin 
and cytokeratin were seen in occasional MyECs. The above 
mentioned results and those figures from this study suggest 
that MyECs are not too common in the neoplastic tissues 
of the PAs as it is generally believed and that they are not 
the main neoplastic component of the PAs.
In our best knowledge, this is the first work quantitating 
the number of S-100 pro-tein positive MyECs in the neo-
plastic cell population of PAs. Our results demonstrate that 
MyECs only comprise approximately the 27,4% of the total 
neoplastic cell number of the studied PAs and that under 
the experimental conditions followed in this study, they do 
not constitute the main cellular component of the neoplastic 
compartment of the PAs. 
Our cell quantitation showed that total number of  cells 
counted in the analysed PAs is not related with age or gender 
of the patients. Tumours located in major salivary glands 
shower larger numbers of S-100 protein positive MyECs 
but, total numbers of positive cells in the analysed PAs are 
not related with location of the tumours. However, larger 
numbers of MyECs were found in 20 year-old or younger 
patients, a definitive correlation among the above mentioned 
parameters was not encountered.
Individual cell quantification of the MyECs found in the 
analysed PAs showed that plasmacytoid cells were the most 
abundant MyEC. As it is shown in this study, the rela-tive 
frequency of each type of MyEC varied in individual cases. 
Our results showed that the suspicion reported by other 
authors (10-14), regarding that MyECs are not the main 
cellular component of the neoplastic compartment in the 
PAs could be true. We propose it is necessary to achieve 
more studies quantifying PA neoplastic cells with different 
an-tibodies, in order to know the relative frequency of the 
different cells composing PAs.
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